Unknown PHASE3 INTERVENTIONAL 1-arm NCT01034683

Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma

Phase 3 Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Recurrent or Metastatic Esophageal Carcinoma

Sponsor: Taian Cancer Hospital

Conditions Esophageal Carcinoma

Interventions lobaplatin , 5-FU ,leucovorin

Updated 5 times since 2017 Last updated: Jan 4, 2010 Started: Dec 31, 2009 Primary completion: Dec 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Esophageal Carcinoma, this trial is ongoing. The trial is conducted by Taian Cancer Hospital and has accumulated 5 data snapshots since 2009. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Taian Cancer Hospital

Data source: Taian Cancer Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taian, China